Molecular Diagnostics
Genomic Biomarkers Assess Treatment Prognosis in Blood Cancers
The biomarker gene, splicing factor 3B subunit 1, is believed to play a critical role in the prognosis of patients with myelodysplastic syndromes, a group of hematological cancers in which bone marrow does not produce enough healthy blood cells. More...04 Aug 2014
Gold Member
Hematology Analyzer
Medonic M32B
Gold Member
Hybrid Pipette
SWITCH
Gel Cards
DG Gel Cards
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
In Other News
Genetic Mutations Linked to Autism Subtype
Multiple Genes Discovered Are Key to Kidney Cancer
Two New NGS Panels to Improve Inherited Disease and Cancer Diagnostics
Genetic Test Improves Prognosis for Esophageal Cancer
Whole-Exome Sequencing Identifies Mitochondrial Disorder Biomarkers
Blood Test Developed to Indicate Breast Cancer Risk
Gene Type Associated with Higher Risk of Celiac Disease
New Blood Test Identifies Sudden Cardiac Death Risk
New Adiponectin Test Kit Gains CE Approval
Genotyping Performed by FRET-PCR Without DNA Extraction
Liver Values Elevated in Overweight Children with Gene Mutation
Simple Urine Test Diagnoses Bladder Cancer Early
MicroRNA Could Help Diagnose Mental Disorders
Mutations in the Apolipoprotein C3 Gene Lower Triglyceride Levels and Reduce Heart Disease Risk
High-Risk Female Groups Screened for Fabry Disease
Molecular Makeup Uncovered in New Form of Cancer
Prostate Cancer Biomarkers Identified in Seminal Fluid
Four New Genes Added to Inherited Breast Cancer Risk List
New Test Improves Reliability of Melanoma Diagnosis
DNA Blood Test Evaluated for Colorectal Cancer Detection
New Genetic Sequencing Methods Means Accurate Embryo Screening
New Software Tool Rapidly Finds Links Between Mutations and Disease in Families
Exome Sequencing Covers Specific Gene Sets Ineffectually
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
